8月13日 - ** 制药公司Journey Medical（DERM.O ） 的股价在盘前交易中上涨6.7%，至6.86美元
** 据伦敦证券交易所集团（LSEG）汇总的数据，该公司第二季度营收 为1850万美元，超出分析师平均预期的1840万美元
** B. Riley分析师表示，这一业绩有力支持了DERM的投资论点，即增长将来自产品销量和平均售价的提升
** 该公司销售和推广经美国食品药品监督管理局（FDA）批准的处方药，用于治疗各种皮肤病
** 公司报告第二季度每股亏损1美分 ，而分析师平均预期为每股亏损2美分
** 截至上一交易日收盘，该公司股票今年以来累计下跌16.6%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.